CG Oncology, Inc. (CGON) - Cash per Single Share

CG Oncology Therapeutics - graphic logo of issuer CGON

Anticipation of the Phase 3 gene therapy trial results and development costs are already priced into CG Oncology, Inc. (CGON) quotes. The historical cash per share level helps assess the issuer's financial resilience, where 11.01 is recorded as the baseline value. CG Oncology, Inc. (CGON) leads the field of oncolytic immunotherapy by creating bioengineered viruses. The application of such drugs against bladder cancer provides a competitive market advantage.

CGON CG Oncology Inc: Cash Funds per Share in the range 02/21/2024 - 11/21/2026

Comprehensive metric breakdowns and analytics for cgoncology.com (CGON)

- current price and projected stock value:
- cash availability and cash flow indicators:
General company analysis:CGON (CG Oncology, Inc.)
Original product of CG Oncology, Inc.

This indicator measures the ratio of liquid reserves to the total number of shares, allowing for the rapid identification of equity dilution between quarterly reports. By analyzing the history of cash per share, an investor assesses the financial stability of CG Oncology, Inc. (CGON), whose significant pricing power in the inelastic demand segment for oncolytic therapy requires efficient capital management to sustain the pace of innovation.

Competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|Amount of Cash per Share URGN|BCAX: Cash per Single Share|PSNL: Cash Funds per Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com